Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hengkang Medical Group Co Ltd

+ Add to Watchlist

002219:CH

30.180 CNY 0.120 0.40%

As of 03:00:28 ET on 03/30/2015.

Snapshot for Hengkang Medical Group Co Ltd (002219)

Open: 30.250 Day's Range: 29.850 - 30.800 Volume: 7,222,598
Previous Close: 30.300 52wk Range: 16.900 - 32.630 1-Yr Rtn: +23.89%

Stock Chart for 002219

No chart data available.
  • 002219:CH 30.180
  • 1D
  • 1M
  • 1Y
30.300
Interactive 002219 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002219

Current P/E Ratio (ttm) 74.2670
Estimated P/E(12/2014) 60.3600
Relative P/E vs. SZASHR 1.5258
Earnings Per Share (CNY) (ttm) 0.4064
Est. EPS (CNY) (12/2014) 0.5000
Est. PEG Ratio -
Market Cap (M CNY) 18,600.81
Shares Outstanding (M) 616.33
30 Day Average Volume 10,589,290
Price/Book (mrq) 19.0736
Price/Sale (ttm) 27.6043
Dividend Indicated Gross Yield -%
Cash Dividend (CNY) 0.0714
Dividend Ex-Date 02/28/2014
5 Year Dividend Growth 52.38%
Next Earnings Announcement 04/22/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002219

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 002219

HengKang Medial Group engages in the R&D, manufacturing, and sales of pharmaceuticals then further expanded its operations to retail health products and provide health care services through the acquisition of hospitals.

Duan ZhipingChairmanXie HaiPresident
Shi XiaomingVice PresidentMo An-MinVice President
More Company Profile & Key Executives for 002219

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil